After a slow start to the week, we’re excited to get back on track Tuesday morning.
Our previous alert is still a rock bottom bargain – a sub penny stock with an awesome story. Bio-Solutions Corporation (BISU.otc) has a product that helps solve a problem 275 million people deal with on a global scale. The company is also trading below a penny meaning that even a minor price gain could bring a major percentage gain, which is what we want for our members.
The stock closed Monday at $0.009.
BISU owns and markets Type2 Defense(TM) a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. Affecting millions of Americans, Type 2 Diabetes is the most common form of diabetes.
Let’s take a look at just how big the market BISU has chosen is…
Diabetes is projected to cost $500 billion by 2020. That’s a tenth of all health care spending $3.4 trillion in total costs over the next 10 years. Currently over 275 million people suffer from diabetes across the globe. This population is expected to exceed 350 million by 2030. Over 133 Million Americans have been diagnosed with Type II Diabetes and many more are unaware they are at high risk. Some groups have a higher risk for developing Type II Diabetes than others. Increasing at about Two Million new American patients per year.
Pretty big pie to grab a slice of for BISU, even a fraction of a fraction of this market could mean serious revenue for the company.
And BISU is taking the necessary steps to gain that fraction. Recently, BISU announced that they are now selling their products on AMAZON.COM! That’s some serious news to get investors excited.
This is an exciting story with serious revenue potential, with a large awareness campaign kicking off Tuesday, BISU could start making some major waves in the OTC market. Coming from a subpenny, any kind of move could bring investors sizable percentage gains.
Make sure, BISU is on top of your watchlist Tuesday.
Additional Research here:
Company Website: http://BioSolutionsCorp.com
Detailed Quote:http://finance.yahoo.com/q?s=bisu&ql=1
